INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
INMB Key Statistics
Stock Snapshot
As of today, INmune Bio(INMB) shares are valued at $1.62. The company's market cap stands at 43.09M, with a P/E ratio of -0.96.
As of 2026-07-25, INmune Bio(INMB) stock has fluctuated between $1.61 and $1.71. The current price stands at $1.62, placing the stock +0.6% above today's low and -5.1% off the high.
The INmune Bio(INMB)'s current trading volume is 185.23K, compared to an average daily volume of 632.64K.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $3.24 and a 52-week low of $1.09.
In the last year, INmune Bio(INMB) shares hit a 52-week high of $3.24 and a 52-week low of $1.09.
INMB News
INmune Bio (INMB) announced the company has successfully processed its first commercial-ready umbilical cord tissue at the Cell and Gene Therapy Catapult Manufa...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.